# A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM

> **NCT06976606** · — · RECRUITING · sponsor: **Lexeo Therapeutics** · enrollment: 40 (estimated)

## Conditions studied

- Arrhythmogenic Cardiomyopathy
- PKP2-ACM
- PKP2-ARVC

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06976606
- **Lead sponsor:** Lexeo Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-23
- **Primary completion:** 2027-07
- **Final completion:** 2027-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06976606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06976606, "A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06976606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*